Researchers have found that users of Ozempic, Mounjaro and similar drugs are less likely to experience opioid overdoses or alcoholism.
Many participants reported similar gastrointestinal side effects as those linked to Ozempic and Wegovy when using the proposed weight loss pill.
Awareness of Ozempic and Wegovy side effects may be driving more younger patients to report adverse events linked to the drugs, researchers speculate.
While no data was available on why patients quit taking Ozempic and Wegovy, the drugs have been linked to reports of severe gastrointestinal side effects and stomach paralysis in some users.
Lawsuit claims Novo Nordisk failed to warn that the risk of Wegovy gastroparesis side effects was dose-specific, meaning the higher the dose, the more likely stomach paralysis would occur.
Lawsuit indicates that side effect of Wegovy caused a Kentucky woman to develop stomach paralysis and a bowel obstruction, which resulted in multiple days of hospitaliation and left her with long-term gastrointestinal damage
New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro
